References
- NIH Consensus Development Panel. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65–71
- Tytgat G NJ, Noach L A. H. pylori eradication, R H Hunt, G NJ Tytgat. Kluwer, Dordrecht 1994; 550–69
- McCarthy C J, Collins R, Beattie S, Hamilton H, O'Morain C. Short report: treatment of Helicobacter pylori associated duodenal ulcer with omeprazole plus antibiotics. Aliment Pharmocol Ther 1993; 7: 463–6
- De Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817–20
- Unge P. Helicobacter pylori eradication therapy—involving proton pump inhibitors. Scand J Gastroenterol 1995, (in press).
- Berstad A. Helicobacter pylori eradication therapy. Scand J Gastroenterol 1995, (in press).
- McNulty C AM, Dent J C, Ford G A, Wilkinson S P. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J Antimicrob Chemother 1988; 22: 729–38
- Quintero Diaz M, Sotto Eschobar A. Metronidazole versus cimetidine in the treatment of gastroduodenal disease. Lancet 1986; I: 907
- Peterson W L, Sontag S L, Ciociola D L, et al. Ranitidine bismuth citrate plus clarithromycin is effective in the eradication of Helicobacter pylori and prevention of duodenal ulcer relapse. Gut 1995; 37 Suppl 1: A5
- Hunt R, Schwartz H, Fitch D, et al. Dual therapy of clarithromycin and omeprazole for treatment of patients with duodenal ulcers associated with H. pylori infection. Gut 1995; 37 Suppl 1: A5
- Georgopoulos S, Stambolos P, Mentis A, et al. Evaluation of the efficacy of clarithromycin in the eradication of Helicobacter pylori. Gut 1995; 37 Suppl 1: A85
- Xia H, Daw M A, Sant S, Beattie S, Keane C T, O'Morain C. Clinical efficacy of triple therapy in Helicobactor pylori associated duodenal ulcer. Eur J Gastroenterol Hepatol 1993; 5: 141–4
- Hunt R H. Ph and Hp—gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism. Am J Gastroenterol 1993; 88: 481–3
- Hentschel E, Brandstatter G, Gragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308–12
- Spadaccini A, De Fanis C, Sciampa G, et al. Ranitidine versus omeprazole: short-term triple therapy in patients with Helicobacter pylori positive duodenal ulcer. Gut 1995; 37 Suppl 1: A42
- Burette A, Glupczynski Y, Deprez C. Evaluation of various multi-drug eradication regimens for Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 817–23
- Tham T CK, Collins J SA, McCormick C, et al. Ranitidine and omeprazole and their combination with antibiotics in the eradication of Helicobacter pylori: a randomised controlled trial. Gut 1995; 37 Suppl 1: A55
- Lam S K. Implications of sucralfate-induced ulcer healing and relapse. Am J Med 1989; 86 Suppl 6A: 122–26
- Hui W M, Lam S K, Ho J, et al. Effect of sucralfate and cimetidine on duodenal ulcer associated antral gastritis and Campylobacter pylori. Am J Med 1989; 86 Suppl 6A: 60–5
- Slomiany B L, Piotrowski J, Slomiany A. Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori proteases and upases. Am J Gastroenterol Hepatol 1992; 87: 599–7
- Hu W HC, Lam S K, Ho J, et al. Gastric metaplasia, Helicobacter pylori and the healing and relapse of duodenal ulcer. J Gastroenterol Hepatol 1993; 8 Suppl 2: S263
- Louw J A, Zak J, Lucke W, et al. Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates. Scand J Gastroenterol 1992; 27 Suppl 191: 28–31
- Hu W HC, Lam S K, Ching C K, et al. New prospects in Helicobacter pylori eradication. Scand J Gastroenterol 1995, (in press).
- Winter T, Louw J, Marks I, et al. The effect of sucralfate on Helicobacter pylori status and gastritis in duodenal ulcer patients. Scand J Gastroenterol 1995; 30 Suppl 210: 85–8
- Slomiany B, Piotrowski J, Majka J, Slomiany A. Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents. Scand J Gastroenterol 1995; 30 Suppl 210: 82–4
- Ghiara P, Marchetti M, Di Tommaso A, et al. Infection by Helicobacter pylori in a mouse model that mimics human disease protection by oral vaccination. Gut 1995; 37 Suppl 1: A51
- Monath T P, Kleanthous H, Lee C K, et al. Development of a recombinant Helicobacter pylori urease as an oral vaccine: current status. Gut 1995; 37 Suppl 1: A52